217 related articles for article (PubMed ID: 10661405)
1. Structure and dimerization of a soluble form of B7-1.
Ikemizu S; Gilbert RJ; Fennelly JA; Collins AV; Harlos K; Jones EY; Stuart DI; Davis SJ
Immunity; 2000 Jan; 12(1):51-60. PubMed ID: 10661405
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.
Zhang X; Schwartz JC; Almo SC; Nathenson SG
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2586-91. PubMed ID: 12606712
[TBL] [Abstract][Full Text] [Related]
3. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
4. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
5. Identification of protein-protein interfaces implicated in CD80-CD28 costimulatory signaling.
Sørensen P; Kussmann M; Rosén A; Bennett KL; Thrige Dda G; Uvebrant K; Walse B; Roepstorff P; Björk P
J Immunol; 2004 Jun; 172(11):6803-9. PubMed ID: 15153498
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
[TBL] [Abstract][Full Text] [Related]
7. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
[TBL] [Abstract][Full Text] [Related]
8. Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen.
Hayden MS; Grosmaire LS; Norris NA; Gilliland LK; Winberg G; Tritschler D; Tsu TT; Linsley PS; Mittler RS; Senter PD; Fell HP; Ledbetter JA
Tissue Antigens; 1996 Oct; 48(4 Pt 1):242-54. PubMed ID: 8946677
[TBL] [Abstract][Full Text] [Related]
9. Novel transcripts encoding secreted forms of feline CD80 and CD86 costimulatory molecules.
Yang S; Sellins KS; Powell T; Stoneman E; Sim GK
Vet Immunol Immunopathol; 2001 Aug; 81(1-2):15-21. PubMed ID: 11498243
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
Stamper CC; Zhang Y; Tobin JF; Erbe DV; Ikemizu S; Davis SJ; Stahl ML; Seehra J; Somers WS; Mosyak L
Nature; 2001 Mar; 410(6828):608-11. PubMed ID: 11279502
[TBL] [Abstract][Full Text] [Related]
11. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
[TBL] [Abstract][Full Text] [Related]
12. Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering.
Yu C; Sonnen AF; George R; Dessailly BH; Stagg LJ; Evans EJ; Orengo CA; Stuart DI; Ladbury JE; Ikemizu S; Gilbert RJ; Davis SJ
J Biol Chem; 2011 Feb; 286(8):6685-96. PubMed ID: 21156796
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP
J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mouse and human B7-H3 genes.
Sun M; Richards S; Prasad DV; Mai XM; Rudensky A; Dong C
J Immunol; 2002 Jun; 168(12):6294-7. PubMed ID: 12055244
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1.
Davis SJ; Ikemizu S; Collins AV; Fennelly JA; Harlos K; Jones EY; Stuart DI
Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):605-8. PubMed ID: 11264596
[TBL] [Abstract][Full Text] [Related]
17. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
[TBL] [Abstract][Full Text] [Related]
19. Refolding and characterization of recombinant human soluble CTLA-4 expressed in Escherichia coli.
Cox GN; Pratt D; Smith D; McDermott MJ; Vanderslice RW
Protein Expr Purif; 1999 Oct; 17(1):26-32. PubMed ID: 10497065
[TBL] [Abstract][Full Text] [Related]
20. Differential down-regulation of CD28 by B7-1 and B7-2 engagement.
Eck SC; Chang D; Wells AD; Turka LA
Transplantation; 1997 Nov; 64(10):1497-9. PubMed ID: 9392322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
